| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2582615A1 Pharmaceutical composition for treatment of tear and salivary fluid drying |
| 04/13/2006 | CA2582327A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | CA2582300A1 Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient |
| 04/13/2006 | CA2582294A1 Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders |
| 04/13/2006 | CA2582256A1 Substituted tricyclic benzimidazoles |
| 04/13/2006 | CA2581921A1 Benzoxazine and quinoxaline derivatives and uses |
| 04/12/2006 | EP1645288A1 New nuclear transcription factors regulators |
| 04/12/2006 | EP1645198A1 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 04/12/2006 | EP1644742A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 04/12/2006 | EP1644482A1 Novel galactooligosaccharide composition and the preparation thereof |
| 04/12/2006 | EP1644327A1 Kappa agonists, especially for the treatment and/or prophylaxis of irritable bowel syndrome |
| 04/12/2006 | EP1644086A1 Use of whey permeate for the treatment of metabolic syndrome |
| 04/12/2006 | EP1644043A1 Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
| 04/12/2006 | EP1441689B1 Solid oral compositions |
| 04/12/2006 | EP1358183B1 Cysteine protease inhibitors |
| 04/12/2006 | EP1355639B1 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1299089B1 Drug delivery system for poorly water soluble drugs |
| 04/12/2006 | EP1297116B1 Method for isolating and purifying a protein |
| 04/12/2006 | EP1280541B1 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1233767B1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2006 | EP1207873A4 Methods of inhibiting osteoclast activity |
| 04/12/2006 | EP1144435B1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1032555B1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 04/12/2006 | EP0942739B1 Biomaterial derived from vertebrate liver tissue |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1757648A Mangiferin derivatives and its prepn. method, and use as medicine |
| 04/12/2006 | CN1757410A Recipe and prodn. method of medicine for pancrease-prevention and keeping in good health |
| 04/12/2006 | CN1757409A Recipe of Wanshou capsule, and health-care function |
| 04/12/2006 | CN1757407A Traditional Chinese medicine pills for treating toothache, and its prepn. method |
| 04/12/2006 | CN1757401A Oral nebula contg. Rosmarinus extractive |
| 04/12/2006 | CN1757397A Biological deodorization method for dried oviduct fat of forest frog |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 04/12/2006 | CN1250546C Tetrahydropyrido compound |
| 04/12/2006 | CN1250545C Quinuclidine derivatives and medicine composition containing the derivatives |
| 04/12/2006 | CN1250292C Freeze-dried pantoprazole preparation and pantoprazole injection |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250284C Hepatitis A inactivated vaccine |
| 04/12/2006 | CN1250283C Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250271C Zhenge lozenge having sobering, liver protection and stomach protection health function |
| 04/12/2006 | CN1250269C Tibetan medical liquor for nourishing kidney |
| 04/12/2006 | CN1250263C Pure Chinese medicinal mixture with spleen benefiting, stomach strengthening, food retention removing and parasites killing function |
| 04/12/2006 | CN1250255C Chinese herbal medicine combination for treating disease of disorder of bowels's function and its product |
| 04/12/2006 | CN1250247C Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation |
| 04/12/2006 | CN1250230C Application of fur seal oil in preparation of medicine for treating fatty liver |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/12/2006 | CN1250217C Bifendate oral disintegration tablet and its preparing process |
| 04/12/2006 | CN1250216C Medication for treating acute hepatitis and chronic hepatitis and preparation technique |
| 04/11/2006 | US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 04/11/2006 | US7026501 Inhibitors of α4 mediated cell adhesion |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026469 Compositions and methods of double-targeting virus infections and cancer cells |
| 04/11/2006 | US7026457 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 04/11/2006 | US7026445 Human SDF-5 protein and compositions |
| 04/11/2006 | US7026361 Dispersion stability; forming protective colloid; bioavailability; hypotensive agents, oral diseases |
| 04/11/2006 | US7026356 Fatty acid analogues for the treatment of diseases caused by the pathological proliferation of smooth muscle cells |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026320 Serotonergic agents |
| 04/11/2006 | US7026318 Compounds exhibiting X-type sPLA2 inhibiting effect |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | US7026309 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/11/2006 | US7026161 Lactobacillus sp. strain and use thereof |
| 04/11/2006 | US7026130 screening chemical compounds for ability to compete with hepatitis C virus for binding to a HCV receptor by comparing the binding of the HCV receptor to the E2 protein of HCV in the presence of said compound to the binding of the receptor to the protein in the absence of the compound |
| 04/11/2006 | US7025995 plant extracts; synergistic |
| 04/11/2006 | US7025993 Herbal composition PHY906 and its use in chemotherapy |
| 04/11/2006 | US7025983 Water soluble film forming polymer |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/11/2006 | CA2329922C Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 04/11/2006 | CA2089440C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicaments containing them |
| 04/11/2006 | CA2089439C 3,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 04/06/2006 | WO2006036670A1 Sulfonamide compounds |
| 04/06/2006 | WO2006036512A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 04/06/2006 | WO2006036507A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036480A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036213A2 The use of gammaglobulin for the treatment of periodontal disease |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006035954A1 Carbostyril compound |
| 04/06/2006 | WO2006035900A1 Coenzyme q10-containing emulsified composition |
| 04/06/2006 | WO2006035821A1 Composition for oral cavity |
| 04/06/2006 | WO2006035308A1 Histamine-3 receptor antagonists |
| 04/06/2006 | WO2006035303A1 Muscarinic receptor antagonists |
| 04/06/2006 | WO2006035280A1 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
| 04/06/2006 | WO2006035061A1 Hcv inhibiting bi-cyclic pyrimidines |
| 04/06/2006 | WO2006034873A1 METHODS FOR THE GENERATION OF HEPATOCYTE-LIKE CELLS FROM HUMAN BLASTOCYST-DERIVED STEM (hBs) |
| 04/06/2006 | WO2006034587A1 Rehydration compositions comprising epidermal growth factor |